Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Daniels

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 3, 2008
Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogenNicole R Miller, R Nathan Daniels, Thomas M Bridges, et al.
Journal of Alzheimer'S Disease : JAD|June 16, 2020
Selective Peripheral Taste Dysfunction in APP/PS1 Mutant Transgenic MiceRyan M Wood, Zacnite Garcia, Nathan Daniels, et al.
The Journal of Organic Chemistry|November 14, 2009
Progress toward the total synthesis of lucentamycin A: total synthesis and biological evaluation of 8-epi-lucentamycin AR Nathan Daniels, Bruce J Melancon, Emily A Wang, et al.
ACS Chemical Biology|December 22, 2009
In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitorsJijun Hao, Joshua N Ho, Jana A Lewis, et al.
Chemical Research in Toxicology|June 1, 2018
Cytochromes P450 1A2 and 3A4 Catalyze the Metabolic Activation of SunitinibGracia M Amaya, Rebecca Durandis, David S Bourgeois, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Approach for targeting Ras with small molecules that activate SOS-mediated nucleotide exchangeMichael C Burns, Qi Sun, R Nathan Daniels, et al.
Journal of Medicinal Chemistry|December 19, 2012
Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based designAnders Friberg, Dominico Vigil, Bin Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2014
Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: development of a [3.3.0]-based series and other piperidine bioisosteresDouglas J Sheffler, Michael T Nedelcovych, Richard Williams, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2017
Corrigendum to "Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: Development of a [3.3.0]-based series and other piperidine bioisosteres" [Bioorg. Med. Chem. Lett. 24 (2014) 1062-1066]Douglas J Sheffler, Michael T Nedelcovych, Richard Williams, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2008
Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moietiesThomas M Bridges, Ashley E Brady, J Phillip Kennedy, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|October 3, 2008
Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogenNicole R Miller, R Nathan Daniels, Thomas M Bridges, et al.
Journal of Alzheimer'S Disease : JAD|June 16, 2020
Selective Peripheral Taste Dysfunction in APP/PS1 Mutant Transgenic MiceRyan M Wood, Zacnite Garcia, Nathan Daniels, et al.
The Journal of Organic Chemistry|November 14, 2009
Progress toward the total synthesis of lucentamycin A: total synthesis and biological evaluation of 8-epi-lucentamycin AR Nathan Daniels, Bruce J Melancon, Emily A Wang, et al.
ACS Chemical Biology|December 22, 2009
In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitorsJijun Hao, Joshua N Ho, Jana A Lewis, et al.
Chemical Research in Toxicology|June 1, 2018
Cytochromes P450 1A2 and 3A4 Catalyze the Metabolic Activation of SunitinibGracia M Amaya, Rebecca Durandis, David S Bourgeois, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Approach for targeting Ras with small molecules that activate SOS-mediated nucleotide exchangeMichael C Burns, Qi Sun, R Nathan Daniels, et al.
Journal of Medicinal Chemistry|December 19, 2012
Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based designAnders Friberg, Dominico Vigil, Bin Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2014
Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: development of a [3.3.0]-based series and other piperidine bioisosteresDouglas J Sheffler, Michael T Nedelcovych, Richard Williams, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2017
Corrigendum to "Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: Development of a [3.3.0]-based series and other piperidine bioisosteres" [Bioorg. Med. Chem. Lett. 24 (2014) 1062-1066]Douglas J Sheffler, Michael T Nedelcovych, Richard Williams, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2008
Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moietiesThomas M Bridges, Ashley E Brady, J Phillip Kennedy, et al.
Pageof 3